Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of DW1501 Combination Treatment in Hypertension and Dyslipidemia
NCT03210532Phase 3Completed
- Sponsor
- Daewon Pharm
- Start
- Oct 2016
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, amlodipine, rosuvastatin in hypertension (HTN), dyslipidemia, sponsored by Daewon Pharm. Started Oct 2016; status: completed.
02
Drugs
telmisartanamlodipinerosuvastatin
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT03210532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03210532.